Skip to content
Research Article Open access CC BY 4.0

Comparative Antimicrobial Activity of Lactobacillus acidophilus and Lactobacillus rhamnosus on Clinically Isolated Escherichia coli: An In vitro Study

Nithyamol Kuriakose, Ananthu Raj, Anju Anil, Azhar M M, Sajmi Sathar, Anagha S, Harish Kumar K S

Microbiology Research Journal International · pp. 31–42 · Published 31 Dec 2023

10.9734/mrji/2023/v33i11-121418

Abstract

Aim: The aim of present study is to evaluate the comparative antimicrobial activity of Lactobacillus acidophilus and Lactobacillus rhamnosus on clinical isolates of Escherichia coli. Study Design:  Cross-sectional observational study. Place and Duration of Study: This study was conducted in Department of Medical Microbiology, School of Medical Education between January 2023 to September 2023. Methodology: A total of 100 E. coli isolates collected from various diagnostic laboratories were included in the sample population and the prevalence of XDR, MDR, and non MDR isolates among them were determined by Kirby-Bauer disk diffusion method. The inhibitory activity of untreated and treated (pH adjusted) suspension of standard strains of L. acidophilus and L. rhamnosus on E. coli were determined by agar overlay method and the data was statistically analysed using ANOVA single-factor. Results: The antimicrobial activity was confirmed for untreated and treated suspension of Lactobacillus spp. by measuring the zone of inhibition surrounding E. coli strains spotted on MRS medium but treated suspension exerted greater inhibitory activity than untreated suspensions of both Lactobacillus spp. and among the treated suspension L. rhamnosus exhibit greater inhibitory activity. Statistical analysis of this data using ANOVA single-factor was found to be not significant (P >0.05), that is treated suspension of both L. acidophilus and L. rhamnosus has the independent activity against E. coli. While untreated suspensions of both L. acidophilus and L. rhamnosus was significant (P =0.03), that is untreated suspension of L. rhamnosus (mean inhibition of 12.19 mm) has greater inhibitory activity than untreated cell cultures of L. acidophilus (mean inhibition of 11.39 mm). Conclusion: This result, disclosed that even if both Lactobacillus spp. exhibit antimicrobial activity against E. coli, L. rhamnosus showed greater inhibition than L. acidophilus. The study suggested the use probiotic Lactobacillus as a biotherapeutic in antibiotic resistant E. coli infection and should be further studied for their human health benefits.

Probiotics antimicrobial resistance Escherichia coli XDR MDR Lactobacillus rhamnosus Lactobacillus acidophilus

References (27)

  1. 1 Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance [DOI]
  2. 2 Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature [DOI]
  3. 3 In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings [DOI]
  4. 4 Screening of Probiotic Activities of Forty-Seven Strains of Lactobacillus spp. by In Vitro Techniques and Evaluation of the Colonization Ability of Five Selected Strains in Humans [DOI]
  5. 5 Microbiota restoration: natural and supplemented recovery of human microbial communities [DOI]
  6. 6 Role of Probiotics in Human Gut Microbiome-Associated Diseases [DOI]
  7. 7 Virulence Factors of Enteric Pathogenic Escherichia coli: A Review [DOI]
  8. 8 Probiotic Potential ofLactobacillusStrains with Antimicrobial Activity against Some Human Pathogenic Strains [DOI]
  9. 9 In vitro evaluation of the antimicrobial activity of a range of probiotics against pathogens: Evidence for the effects of organic acids [DOI]
  10. 10 Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens [DOI]
  11. 11 Salmonella infection – prevention and treatment by antibiotics and probiotic yeasts: a review [DOI]
  12. 12 Antimicrobial activity and antibiotic susceptibility ofLactobacillusandBifidobacteriumspp. intended for use as starter and probiotic cultures [DOI]
  13. 13 Antimicrobial properties of Lactobacillus cell‐free supernatants against multidrug‐resistant urogenital pathogens [DOI]
  14. 14 Efficacy of Using Probiotics with Antagonistic Activity against Pathogens of Wound Infections: An Integrative Review of Literature [DOI]
  15. 15 Potential probiotic properties of lactic acid bacteria isolated from the intestinal mucosa of healthy piglets [DOI]
  16. 16 Probiotic properties and antimicrobial evaluation of silymarin-enriched Lactobacillus bacteria isolated from traditional curd [DOI]
  17. 17 Microbial Inhibition by an Isolate of Pediococcus from Cucumber Brines [DOI]
  18. 18 A Comparison of Two Methods Used for Measuring Antagonistic Activity of Lactic Acid Bacteria [DOI]
  19. 19 Study of the In Vitro Antagonistic Activity of Various Single-Strain and Multi-Strain Probiotics against Escherichia coli [DOI]
  20. 20 Antimicrobial Activity of Lactobacillus spp. Isolated From Fecal Flora of Healthy Breast-Fed Infants Against Diarrheagenic Escherichia coli [DOI]
  21. 21 In vitroactivity of commercial probioticLactobacillusstrains against uropathogenicEscherichia coli [DOI]
  22. 22 Antibiotic therapy for pan-drug-resistant infections [DOI]
  23. 23 Multidrug resistant, extensively drug resistant and pan drug resistant gram negative bacteria at a tertiary care centre in Bhubaneswar [DOI]
  24. 24 The Emergence of Multidrug-Resistant (MDR), Extensively Drug-Resistant (XDR), and Pandrug-Resistant (PDR) In Iraqi Clinical Isolates of Escherichia coli [DOI]
  25. 25 A Diagnostic Quandary of Escherichia Coli Pneumonia: A Case Report and Literature Review [DOI]
  26. 26 Antibacterial Potentiality of Commercially Available Probiotic Lactobacilli and Curd Lactobacilli Strains, Alone and in Combination, against Human Pathogenic Bacteria [DOI]
  27. 27 Antibacterial activity of bacteriocin isolated from Lactobacillus acidophilus against throat infections causing bacteria [DOI]

Cited by 2

16S rRNA–Based Identification and Probiotic Potential of Lactobacilli Isolated from Asymptomatic COVID-19 Individuals

Jugalkumari Shah, Parul Shrivastava · EPJ Web of Conferences · 2026

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

51

Page views

0

PDF downloads

10

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.